Group One Trading
AUTL

Group One Trading’s Autolus Therapeutics AUTL Stock Holding History

Group One Trading’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,600
Closed -$23.8K – 8110
2025
Q3 		$23.8K Hold
14,600
– – ﹤0.01% 6565
2025
Q2 		$33.3K Buy
14,600
+13,800
+1,725% +$22.8K ﹤0.01% 5892
2025
Q1 		$1.24K Sell
800
-10,900
-93% -$22.1K ﹤0.01% 7130
2024
Q4 		$27.5K Buy
11,700
+10,700
+1,070% +$36.2K ﹤0.01% 5497
2024
Q3 		$3.63K Buy
+1,000
New +$3.99K ﹤0.01% 5996
2024
Q2 		– Sell
-1,400
Closed -$8.93K – 6696
2024
Q1 		$8.93K Buy
+1,400
New +$8.73K ﹤0.01% 5927

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's AUTL Position: Q4 2025 in Review

Group One Trading sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 8,381 shares — an estimated $12.9K sold.

Group One Trading first reported a position in AUTL in Q3 2021 and held it in 7 quarters. The position peaked at $24K in Q1 2022. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • Group One Trading reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 8,381 Autolus Therapeutics shares in Q4 2025, an estimated $12.9K.
  • Group One Trading first reported a position in Autolus Therapeutics in Q3 2021 and held it in 7 quarters.
  • Group One Trading's Autolus Therapeutics position peaked at $24K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.